VendorInvestigate: difference between revisions
Diff·revision 12 → 13·00:36, 25 Jan 2025
Difference between revision 12 and revision 13 of VendorInvestigate. 6 lines changed; the page grew by 102 bytes.
| Revision 12 — 20:06, 10 Jan 2025 LeanMassLars (talk) clarify that a signature on a certificate is a release, not a verification 3,483 bytes +43 | Revision 13 — 00:36, 25 Jan 2025 MicrodoseMagnus (talk) add category for certificates of analysis 3,585 bytes +102 | ||
|---|---|---|---|
| 32 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 32 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 33 | 33 | ||
| + | 34 | == See also == | |
| + | 35 | * [[Third-party testing]] | |
| + | 36 | * [[Janoshik Analytical]] | |
| + | 37 | * [[Medutest]] | |
| + | 38 | * [[PeptideMeter]] | |
| + | 39 | ||
| 34 | {{DEFAULTSORT:VendorInvestigate}} | 40 | {{DEFAULTSORT:VendorInvestigate}} |
| 35 | [[Category:Independent testing services]] | 41 | [[Category:Independent testing services]] |